Explore

Rapid Read Rapid Read
Chikungunya Vaccine Study Highlights Efficacy of Single-Dose Regimen

Chikungunya Vaccine Study Highlights Efficacy of Single-Dose Regimen

A recent systematic review and meta-analysis have evaluated the efficacy and safety of single-dose versus two-dose chikungunya vaccines. The study, which analyzed data from various randomized controlled trials, found that single-dose vaccines demonstrated a significantly higher seroresponse compared to controls, with a risk ratio of 89.43. However, adverse events were more frequent in the single-dose group. The analysis revealed that single-dose regimens had a seroresponse rate of 98.0%, compared to 70.8% for two-dose regimens. Despite the promising results, the study noted high heterogeneity across trials, suggesting the need for direct head-to-head comparisons to confirm these findings.
Trendline Trendline
Pharmacist Tips for a Healthy Back-to-School Season

Pharmacist Tips for a Healthy Back-to-School Season

Pharmacist Tips for a Healthy Back-to-School Season
Trendline Trendline
NY Land Quest Offers Unique Property in Bath, NY for Sale

NY Land Quest Offers Unique Property in Bath, NY for Sale

NY Land Quest Offers Unique Property in Bath, NY for Sale
Rapid Read Rapid Read
Study Identifies Risk Factors for Severe Disease in Hospitalized Children with RTIs

Study Identifies Risk Factors for Severe Disease in Hospitalized Children with RTIs

A study conducted at two Canadian pediatric centers has found that more than one in five children hospitalized with acute respiratory tract infections (RTIs) develop severe disease. The research, published in JAMA Network Open, involved 2,585 children hospitalized between July 2022 and June 2023. It identified that children transferred from a referring hospital, those with chronic conditions, and those with specific viral infections are at higher risk for severe outcomes. The study highlighted that influenza is more often associated with acute respiratory distress syndrome (ARDS) and septic shock, while human metapneumovirus is linked to cardiac complications. Despite low mortality rates, the burden of severe illness remains high, emphasizing the need for targeted prevention and ongoing surveillance.
Rochester Democrat and Chronicle Rochester Democrat and Chronicle
Drivers in Geneva, expect delays starting Tuesday. Here's what to know

Drivers in Geneva, expect delays starting Tuesday. Here's what to know

A pavement project will reduce a portion of Route 14 to one lane through Aug. 27, with flaggers controlling alternating traffic during daytime hours.
Rapid Read Rapid Read
FDA Approves First mRNA Flu Vaccine for U.S. Adults Over 50

FDA Approves First mRNA Flu Vaccine for U.S. Adults Over 50

The Food and Drug Administration (FDA) has approved mFlusiva, the first mRNA-based influenza vaccine for adults in the United States. Developed by Moderna, the vaccine is approved for adults over 50, with accelerated approval for those aged 65 and over based on immune response data. The approval comes as mRNA technology, which was pivotal in COVID-19 vaccine development, is being adapted for flu vaccines to improve efficacy against emerging strains. The vaccine demonstrated a 26.6% higher effectiveness compared to traditional flu vaccines in recent trials. However, access for those over 65 is contingent on ongoing clinical trials assessing specific needs for this demographic.
Rapid Read Rapid Read
Stanford's HEAL Network Advances Health Equity Through Innovative Research

Stanford's HEAL Network Advances Health Equity Through Innovative Research

The HEAL Network at Stanford Medicine, led by Dr. Lee Sanders, is making strides in health equity research, focusing on maternal and child health. Dr. Sanders, a professor of pediatrics and health policy, directs the Stanford Health Literacy Lab, which aims to reduce health disparities through innovative primary care redesign. The network conducts multidisciplinary research, including studies on early childhood obesity prevention and AI-driven support for complex medical care. Dr. Sanders' work is supported by federal grants and partnerships with educational institutions, emphasizing the integration of health and education data to address disparities.
Rapid Read Rapid Read
Yemen Faces Severe Immunization Crisis as Houthi Restrictions Persist

Yemen Faces Severe Immunization Crisis as Houthi Restrictions Persist

Yemen is experiencing a significant health crisis due to a collapse in immunization coverage, particularly in the northern governorates controlled by the Houthi group. According to data from the World Health Organization and UNICEF, immunization rates for diseases such as measles, polio, and diphtheria are alarmingly low, with coverage at 41%, 46%, and 55% respectively. The inability to conduct mass vaccination campaigns since 2022 has left over 4.5 million children under five unvaccinated or vulnerable to infection. The crisis is exacerbated by restrictions on door-to-door vaccination campaigns and the spread of vaccine misinformation, which have widened the immunity gap and allowed the virus to continue circulating.
Rapid Read Rapid Read
Senate Confirms Dr. Erica Schwartz as New CDC Director Amid Vaccine Hesitancy Concerns

Senate Confirms Dr. Erica Schwartz as New CDC Director Amid Vaccine Hesitancy Concerns

The Senate has confirmed Dr. Erica Schwartz as the new director of the Centers for Disease Control and Prevention (CDC), marking the agency's first permanent leader in a year. Schwartz, who previously served as deputy surgeon general during President Trump's first term, steps into the role amid rising vaccine hesitancy and ongoing public health challenges, including a measles crisis and a cyclosporiasis outbreak. Her confirmation follows a period of leadership instability at the CDC, with a series of acting directors since August 2025. Schwartz's appointment comes after Health Secretary Robert F. Kennedy Jr. dismissed previous CDC leadership and altered vaccine advisory panels, raising concerns about the agency's direction under his influence.
Rapid Read Rapid Read
Study Links Higher Learning Disabilities in Children to Proximity to Petrochemical Plants in Louisiana

Study Links Higher Learning Disabilities in Children to Proximity to Petrochemical Plants in Louisiana

A new study conducted by the Collaborative Data Analysis and Dillard University has found that children living near petrochemical plants in Louisiana have higher rates of learning disabilities. The research highlights the environmental health risks associated with living in areas with high industrial pollution, particularly in the state's industrial corridor known as Cancer Alley. The study adds to growing concerns about the impact of industrial pollution on public health, especially among vulnerable populations such as children.
Rapid Read Rapid Read
FDA Nears Decision on First mRNA Flu Vaccine Approval

FDA Nears Decision on First mRNA Flu Vaccine Approval

The U.S. Food and Drug Administration (FDA) is on the verge of deciding whether to approve the first flu vaccine utilizing mRNA technology, similar to that used in COVID-19 vaccines. This decision comes amid ongoing debates about the safety and efficacy of mRNA vaccines, with Health Secretary Robert F. Kennedy Jr. expressing skepticism about the technology. The approval of an mRNA flu vaccine could mark a significant advancement in vaccine development, offering a new tool in the fight against influenza.
USA Today USA Today
Universal Studios Hollywood visitors may have been exposed to measles

Universal Studios Hollywood visitors may have been exposed to measles

Health officials warn of potential measles exposure at Universal Studios Hollywood on July 26.